GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SRTOY) » Definitions » E10

Sartorius Stedim Biotech (Sartorius Stedim Biotech) E10 : $0.41 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Sartorius Stedim Biotech E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sartorius Stedim Biotech's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.047. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.41 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Sartorius Stedim Biotech's average E10 Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-24), Sartorius Stedim Biotech's current stock price is $20.72. Sartorius Stedim Biotech's E10 for the quarter that ended in Dec. 2023 was $0.41. Sartorius Stedim Biotech's Shiller PE Ratio of today is 50.54.

During the past 13 years, the highest Shiller PE Ratio of Sartorius Stedim Biotech was 131.04. The lowest was 46.50. And the median was 76.12.


Sartorius Stedim Biotech E10 Historical Data

The historical data trend for Sartorius Stedim Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech E10 Chart

Sartorius Stedim Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.34 0.41

Sartorius Stedim Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.38 0.38 0.45 0.41

Competitive Comparison of Sartorius Stedim Biotech's E10

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius Stedim Biotech's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's Shiller PE Ratio falls into.



Sartorius Stedim Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sartorius Stedim Biotech's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.047/123.7729*123.7729
=0.047

Current CPI (Dec. 2023) = 123.7729.

Sartorius Stedim Biotech Quarterly Data

per share eps CPI Adj_EPS
201012 0.030 94.132 0.039
201106 0.015 95.158 0.020
201112 0.032 95.998 0.041
201206 0.016 96.744 0.020
201212 0.044 97.957 0.056
201306 0.029 98.516 0.036
201312 0.047 99.356 0.059
201406 0.029 99.543 0.036
201412 0.050 99.543 0.062
201506 0.039 100.417 0.048
201512 0.078 99.717 0.097
201606 0.048 100.717 0.059
201612 0.090 101.217 0.110
201706 0.047 102.117 0.057
201709 0.048 102.717 0.058
201712 0.058 102.617 0.070
201803 0.054 102.917 0.065
201806 0.063 104.017 0.075
201809 0.063 104.718 0.074
201812 0.084 104.217 0.100
201903 0.069 104.217 0.082
201906 0.079 105.718 0.092
201909 0.069 106.018 0.081
201912 0.066 105.818 0.077
202003 0.090 105.718 0.105
202006 0.081 106.618 0.094
202009 0.127 105.818 0.149
202012 0.125 105.518 0.147
202103 0.162 107.518 0.186
202106 0.194 108.486 0.221
202109 0.189 109.435 0.214
202112 -0.010 110.384 -0.011
202203 0.323 113.968 0.351
202206 0.246 115.760 0.263
202209 0.216 118.818 0.225
202212 0.219 119.345 0.227
202303 0.130 122.402 0.131
202306 0.156 123.140 0.157
202309 0.030 124.195 0.030
202312 0.047 123.773 0.047

Add all the adjusted EPS together and divide 10 will get our e10.


Sartorius Stedim Biotech  (OTCPK:SRTOY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sartorius Stedim Biotech's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=20.72/0.41
=50.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sartorius Stedim Biotech was 131.04. The lowest was 46.50. And the median was 76.12.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sartorius Stedim Biotech E10 Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius Stedim Biotech (Sartorius Stedim Biotech) Business Description

Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.